GBGB9606372.2A
GB9606372D0
(en)
|
1996-03-26 |
1996-03-26 |
Pharmaceutical formulations
|
MYPI97001186A
MY126358A
(en)
|
1996-03-22 |
1997-03-20 |
Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
|
TR1998/01881T
TR199801881T2
(en)
|
1996-03-22 |
1997-03-21 |
Compositions containing an HIV protease inhibitor such as VX 478 and a water-soluble vitamin E compound such as vitamin E-TPGS.
|
CZ19983035A
CZ289958B6
(en)
|
1996-03-22 |
1997-03-21 |
Pharmaceutical preparation
|
SK1269-98A
SK284244B6
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble Vitamin E compound such as Vitamin E-TPGS
|
CA002249336A
CA2249336C
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
|
PCT/EP1997/001438
WO1997035587A1
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
|
HU9901887A
HU228026B1
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an hiv protease inhibitor and a water soluble vitamin e compound
|
ARP970101146A
AR006345A1
(en)
|
1996-03-22 |
1997-03-21 |
A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INCLUDING AN HIV PROTEASE INHIBITOR AND A WATER-SOLUBLE TOCOFEROL DERIVATIVE, AND A METHOD FOR PREPARING SUCH COMPOSITION.
|
DK97914287T
DK0906107T3
(en)
|
1996-03-22 |
1997-03-21 |
Formulations containing VX478 and a water-soluble Vitamin E compound such as Vitamin E-TPGS
|
CN97193229A
CN1225587A
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS
|
AU21591/97A
AU724239B2
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS
|
IDP970927A
ID16781A
(en)
|
1996-03-22 |
1997-03-21 |
PHARMACEUTICAL FORMULATIONS
|
UA98094710A
UA67723C2
(en)
|
1996-03-26 |
1997-03-21 |
Pharmaceutical formulations for peroral administration and method for its preparation
|
IL12618597A
IL126185A
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an hiv protease inhibitor, a water soluble vitamin e compound and a hydrophilic non-aqueous solvent
|
EP97914287A
EP0906107B1
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
|
RO98-01407A
RO119923B1
(en)
|
1996-03-22 |
1997-03-21 |
Pharmaceutical composition for oral administration
|
EE9800323A
EE04093B1
(en)
|
1996-03-22 |
1997-03-21 |
Preparations containing the HIV protease inhibitor VX 478 and the water-soluble vitamin E derivative vitamin E-TPGS
|
SI9730498T
SI0906107T1
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
|
NZ331645A
NZ331645A
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS
|
DE69718315T
DE69718315T2
(en)
|
1996-03-22 |
1997-03-21 |
PREPARATION, CONTAINING VX 478 AND A WATER-SOLUBLE VITAMIN E COMPOUND LIKE VITAMIN E-TPGS
|
ES97914287T
ES2190528T3
(en)
|
1996-03-22 |
1997-03-21 |
COMPOSITIONS CONTAINING VX478 AND A COMPOSITE OF VITAMIN AND SOLUBLE IN WATER, SUCH AS VITAMIN E-TPGS.
|
TW086103607A
TW455491B
(en)
|
1996-03-22 |
1997-03-21 |
Pharmaceutical composition for oral administration
|
BR9708238A
BR9708238A
(en)
|
1996-03-22 |
1997-03-21 |
Pharmaceutical formulation for oral administration and process for preparing the same
|
EA199800755A
EA001484B1
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluable vitamin e compound such as vitamin e-tpgs
|
AT97914287T
ATE230602T1
(en)
|
1996-03-22 |
1997-03-21 |
PREPARATION CONTAINING VX 478 AND A WATER-SOLUBLE VITAMIN E COMPOUND SUCH AS VITAMIN E-TPGS
|
APAP/P/1998/001343A
AP1150A
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an HIV protease inhibitor such as Vx 478 and a water soluble vitamin E compound such as vitamin E-TPGS.
|
PL32891697A
PL187919B1
(en)
|
1996-03-22 |
1997-03-21 |
Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
|
JP09534017A
JP3117726B2
(en)
|
1996-03-22 |
1997-03-21 |
Compositions comprising an HIV protease inhibitor such as VX478 and a water-soluble vitamin E such as vitamin E-TPGS
|
CO97015457A
CO4790151A1
(en)
|
1996-03-22 |
1997-03-21 |
COMPOSITIONS INCLUDING AN HIV PROTEASE INHIBITOR LIKE VX478 AND A COMPOUND OF VITAMIN E Soluble IN WATER AS VITAMIN E - TPGS
|
GEAP19974496A
GEP20012464B
(en)
|
1996-03-22 |
1997-03-21 |
Compositions Comprising an HIV Protease Inhibitor Such As VX 478 and a Water Soluble Vitamin E Compound Such As Vitamin E-TPGS
|
IS4840A
IS2066B
(en)
|
1996-03-22 |
1998-08-28 |
Compositions comprising VX 478 and a water-soluble vitamin E compound such as vitamin E-TPGS
|
OA9800171A
OA10880A
(en)
|
1996-03-22 |
1998-09-18 |
Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
|
NO19984386A
NO317639B1
(en)
|
1996-03-22 |
1998-09-21 |
Compositions comprising an HIV protease inhibitor such as VX 478 and a water-soluble vitamin E compound such as vitamin E TPGs
|
BG102838A
BG64457B1
(en)
|
1996-03-22 |
1998-10-12 |
Hiv protease inhibitor-containing pharmaceutical form for oral administration
|
HK99102135A
HK1016896A1
(en)
|
1996-03-22 |
1999-05-12 |
Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin etpgs
|
UY25926A
UY25926A1
(en)
|
1996-03-22 |
2000-01-17 |
PHARMACEUTICAL FORMULATIONS OF 3S- (3R * (1R *, 2S *)) - (3 - (((4-AMINOFENIL) SULFONIL) (2-METHYLPROPYL) -AMINO) -2-HYDROXY- ESTER TETRAHIDRO-3-FURANILICO 1-PHENYL METHYL) PROPIL CARBAMIC
|
CY0400050A
CY2444B1
(en)
|
1996-03-22 |
2004-06-23 |
Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs.
|